Skip to main content

Adjuvant nivolumab in resected oesophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapy: Slovenian real-world data Cover

.blurhash-client-img { display: none !important; }

Adjuvant nivolumab in resected oesophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapy: Slovenian real-world data

Radiology and Oncology

By: Nezka Hribernik, Rozala Arko, Gorana Gasljevic and Martina Rebersek

Open Access

|Apr 2026

Figures & tables

Articles in this issue

DOI: https://doi.org/10.2478/raon-2026-0020 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Submitted on: Oct 2, 2025

|

Accepted on: Dec 2, 2026

|

Published on: Apr 16, 2026

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

oesophageal and gastroesophageal junction cancer,

adjuvant immunotherapy,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2026 Nezka Hribernik, Rozala Arko, Gorana Gasljevic, Martina Rebersek, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.